Lanreotide Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of lanreotide that can be used in the treatment of neuroendocrine tumors (NETs), including well-differentiated grade 3 NETs and NETs of the gastrointestinal tract, lung, thymus and pancreas, pheochromocytoma and paraganglioma, and appendiceal adenocarcinoma.

**Synonyms:** - Lanreotide monotherapy - Somatuline Regimen